Cargando…

Prediction of response to bromocriptine in acromegaly.

Detalles Bibliográficos
Autores principales:	Atkinson, A. B., Trimble, E. R., Hadden, D. R., Sheridan, B.
Formato:	Texto
Lenguaje:	English
Publicado:	Ulster Medical Society 1978
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2385834/ https://www.ncbi.nlm.nih.gov/pubmed/653899

Ejemplares similares

Ascertainment and natural history of treated acromegaly in Northern Ireland.
por: Ritchie, C. M., et al.
Publicado: (1990)

Bromocriptine and insulin sensitivity in lean and obese subjects
por: Bahler, L, et al.
Publicado: (2016)

Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.
por: Missale, C., et al.
Publicado: (1995)

Central Hyperthermia Treated with Bromocriptine
por: Natteru, P., et al.
Publicado: (2017)

Repurposing of Bromocriptine for Cancer Therapy
por: Seo, Ean-Jeong, et al.
Publicado: (2018)

Bromocriptine Use in Peripartum Cardiomyopathy: Review of Cases
por: Simon, Rebecca, et al.
Publicado: (2018)

Bromocriptine Does Not Alter Speed–Accuracy Tradeoff
por: Winkel, Jasper, et al.
Publicado: (2012)

Bromocriptine in type 2 diabetes mellitus
por: Shivaprasad, C., et al.
Publicado: (2011)

Repositioning of bromocriptine for treatment of acute myeloid leukemia
por: Lara-Castillo, María Carmen, et al.
Publicado: (2016)

Bromocriptine, a clinical and pharmacological review /
por: Thorner, Michael O.
Publicado: (1980)

Effects of tolcapone and bromocriptine on cognitive stability and flexibility
por: Cameron, Ian G. M., et al.
Publicado: (2018)

Effect of bromocriptine on cardiovascular complications associated with metabolic syndrome in fructose fed rats
por: Nade, Vandana S., et al.
Publicado: (2012)

Effect of Bromocriptine-QR (a Quick-Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
por: Gaziano, J. Michael, et al.
Publicado: (2012)

Management of pituitary tumour apoplexy with bromocriptine in pregnancy
por: Janssen, Nina M, et al.
Publicado: (2012)

Evaluation of the efficacy and safety of bromocriptine QR in type 2 diabetes
por: Ramteke, Karuna Balwant, et al.
Publicado: (2011)

Dopaminergic Challenge With Bromocriptine in Patients With Severe Brain Injury
por: Celik, JB, et al.
Publicado: (2015)

Efficacy of bromocriptine on glycemic and metabolic control of prediabetic patients
por: Khalilzade, Saied Hossein, et al.
Publicado: (2015)

Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
Publicado: (2015)

Bromocriptine inhibits proliferation in the endometrium from women with adenomyosis
por: Tang, Yiqun, et al.
Publicado: (2023)

Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study
por: Hilfiker-Kleiner, Denise, et al.
Publicado: (2017)

Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models
por: Bai, Lijuan, et al.
Publicado: (2023)

Bromocriptine as a new therapeutic agent for peripartum cardiomyopathy
por: Chopra, Sandeep, et al.
Publicado: (2012)

Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine
por: Aslanoglou, Despoina, et al.
Publicado: (2022)

Effects of Bromocriptine on Glucose and Insulin Dynamics in Normal and Insulin Dysregulated Horses
por: Loos, Caroline M. M., et al.
Publicado: (2022)

Bromocriptine Therapy for the Treatment of Invasive Prolactinoma: The Single Institute Experience
por: Cho, Kyung Rae, et al.
Publicado: (2013)

Role of bromocriptine in multi-spectral manifestations of traumatic brain injury
por: Munakomi, Sunil, et al.
Publicado: (2017)

Comparison of bromocriptine and hydroxyethyl starch in the prevention of ovarian hyperstimulation syndrome
por: Zhang, Qiaoli, et al.
Publicado: (2022)

Impact of Nano-Bromocriptine on Egg Production Performance and Prolactin Expression in Layers
por: Dawod, Ahmed, et al.
Publicado: (2021)

Acromegaly and Vaccination
por: Leverson, M. R.
Publicado: (1899)

AB086. The effect of Xuanju compound capsule combined with bromocriptine
por: Bian, Jun, et al.
Publicado: (2016)

Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction
por: Haghikia, Arash, et al.
Publicado: (2018)

A Systematic Review of the Utility of Bromocriptine in Acute Peripartum Cardiomyopathy
por: Badianyama, Marheb, et al.
Publicado: (2021)

The Dopamine Agonist Bromocriptine Differentially Affects Fronto-Striatal Functional Connectivity During Working Memory
por: Wallace, Deanna L., et al.
Publicado: (2011)

Temporal resolution of idiopathic granulomatous mastitis with resumption of bromocriptine therapy for prolactinoma
por: Bouton, Marcia E., et al.
Publicado: (2015)

Prevalence of diabetes mellitus in patients with acromegaly
por: Dreval, A V, et al.
Publicado: (2014)

Effect of prolactin and bromocriptine on growth of transplanted hormone-dependent mouse mammary tumours.
por: Briand, P., et al.
Publicado: (1977)

The Comparative Pharmaco- and Histokinetics of the Therapeutic Dose of Estradiol Valerate and Bromocriptine in Common Quails
por: Nadeem, Muhammad, et al.
Publicado: (2022)

Bromocriptine Reverses P‐Glycoprotein‐mediated Multidrug Resistance in Tumor Cells
por: Shiraki, Nobuaki, et al.
Publicado: (2002)

EFFECT OF FLUOXETINE AND BROMOCRIPTINE ON CRAVING OCCURRING DURING WITHDRAWAL FROM ALCOHOL
por: Chatterjee, Sudipto, et al.
Publicado: (1996)

Acromegaly
por: Gibson, G. A.
Publicado: (1899)

Cannot write session to /tmp/vufind_sessions/sess_1o5n2qt0idn14ckoluqfukbtdm